Benzinga - Gainers
- Forza X1, Inc. (NASDAQ: FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'
- Chijet Motor Company, Inc. (NASDAQ: CJET) shares surged 60.3% to $6.14 in pre-market trading after dipping around 33% on Friday.
- Evaxion Biotech A/S (NASDAQ: EVAX) shares gained 41.8% to $2.17 in pre-market trading after the company announced that its melanoma trial met its primary endpoints. The company said proprietary AI technology pioneer was able to identify high-quality cancer vaccine targets.
- Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) gained 33.8% to $18.19 in pre-market trading after the company announced overall response rate of 67% and clinical benefit rate of 93% in 69 heavily pretreated RANO-HGG evaluable patients in pediatric low-grade glioma trial.
- Golden Minerals Company (NASDAQ: AUMN) shares rose 23.6% to $0.1373 in pre-market trading. Golden Minerals Company recently announced a 1-for-25 reverse stock split.
- Dunxin Financial Holdings Limited (NYSE: DXF) gained 19.6% to $0.2463 in pre-market trading after gaining over 15% on Friday.
- Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 18.1% to $0.35 in pre-market trading. Kaspien recently announced a voluntary delisting from The Nasdaq Capital Market.
- MultiMetaVerse Holdings Limited (NASDAQ: MMV) rose 17.2% to $2.39 in pre-market trading. MultiMetaVerse shares jumped 117% on Friday after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
- Sentage Holdings Inc. (NASDAQ: SNTG) shares gained 17.2% to $2.80 in pre-market trading.
- CBL International Limited (NASDAQ: BANL) rose 11.1% to $3.01 in pre-market trading. CBL International recently reported a 41.8% year-over-year revenue growth in FY22.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Mallinckrodt plc (NYSE: MNK) fell 20.4% to $1.95 in pre-market. Mallinckrodt is considering options including filing for bankruptcy again, according to the Wall Street Journal.
- Yunji Inc. (NASDAQ: YJ) shares dropped 15.5% to $0.2702 in pre-market trading. Yunji shares jumped over 50% on Friday after the company reported first-quarter financial results.
- Minerva Surgical, Inc. (NASDAQ: UTRS) shares dropped 13.9% to $0.2522 in pre-market trading after surging over 46% on Friday.
- Marker Therapeutics, Inc. (NASDAQ: MRKR) fell 13.1% to $1.60 in pre-market trading after gaining around 10% on Friday. Marker Therapeutics recently reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.
- Cyxtera Technologies, Inc. (NASDAQ: CYXT) fell 12.5% to $0.1392 in pre-market trading after the company said, pursuant to the previously disclosed Restructuring Support Agreement it reached with certain of its lenders holding over two-thirds of its outstanding term loan, the Company and certain of its subsidiaries have initiated a pre-arranged court-supervised process under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey.
- Kaixin Auto Holdings (NASDAQ: KXIN) fell 11.1% to $0.3110 in pre-market trading after jumping over 16% on Friday.
- UTime Limited (NASDAQ: UTME) fell 10.4% to $1.81 in pre-market trading after gaining 4% on Friday.
- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares fell 9.6% to $0.2205 in pre-market trading after gaining over 8% on Friday.
- Affimed N.V. (NYSE: AFMD) fell 8.8% to $0.80in pre-market trading. Affimed reported the presentation at the ASCO Annual Meeting of safety and efficacy data from the EGFR mutant NSCLC expansion cohort of its ongoing phase 1/2 study investigating innate cell engager (ICE®) AFM24 as monotherapy.
- SHL Telemedicine Ltd. (NASDAQ: SHLT) fell 8.6% to $11.61 in pre-market trading after gaining 10% on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Market Volatility Falls Sharply Following Jobs Report; S&P 500 Records Weekly Gain
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.